A first-of-its-kind Canadian trial is testing psilocybin, the psychedelic component found in magic mushrooms, on participants to see if it can treat anxiety.
Related Posts
AO boss tells BBC: We’re a British success story – the UK should be turbocharging us
John Roberts, the founder of AO and so-called kitchen king, says tax rises are putting “grit” into businesses.
Accreditation is your hack into GIFT City AIFs
Accreditations enable people with lower investments to access global markets, benefit from tax efficiencies, and diversify portfolios beyond traditional domestic…
We’ve Got Fun Plans for TPM’s 25th Anniversary
I’m sure you’ve noticed that we’re getting set to celebrate the 25th anniversary of TPM, what with all the site…